BIOMAT Database Logo BIOMAT Database Logo

[Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis]. 1986

M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova

UI MeSH Term Description Entries
D007740 L Forms Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
December 1988, Vrachebnoe delo,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Clinical significance of finding mycobacterial L forms in patients with destructive pulmonary tuberculosis].
January 1986, Problemy tuberkuleza,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
December 1985, Klinicheskaia meditsina,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Intrabronchial administration of rifampicin in the complex treatment of patients with destructive pulmonary tuberculosis].
April 1983, Problemy tuberkuleza,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
January 1971, Problemy tuberkuleza,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
June 1978, Problemy tuberkuleza,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Effectiveness of intrabronchial administration of rifampicin in the treatment of patients with destructive pulmonary tuberculosis].
January 1985, Vrachebnoe delo,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
Population Pharmacokinetics of Rifampicin in Chinese Patients With Pulmonary Tuberculosis.
May 2016, Journal of clinical pharmacology,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
January 1971, Problemy tuberkuleza,
M A Karachunskiĭ, and I R Dorozhkova, and V I Chukanov, and Iu E Balta, and L M Kiazimova
[Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
June 1980, Problemy tuberkuleza,
Copied contents to your clipboard!